Recap: AcelRx Pharmaceuticals Q1 Earnings


AcelRx Pharmaceuticals ACRX reported its Q1 earnings results on Wednesday, May 10, 2023 at 04:05 PM.

Here's what investors need to know about the announcement.


AcelRx Pharmaceuticals beat estimated earnings by 3.85%, reporting an EPS of $-0.75 versus an estimate of $-0.78.

Revenue was down $442 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.49 which was followed by a 6.0% drop in the share price the next day.

Here's a look at AcelRx Pharmaceuticals's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.51 -1.20 -1.4 -1.2
EPS Actual -1 -0.94 -1.2 -1.2
Revenue Estimate 4.50M 620K 550K 550K
Revenue Actual 252K 507K 570K 442K

To track all earnings releases for AcelRx Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!